Johnson & Johnson Announces Public-Private Partnership to Support Study of HIV Vaccine
July 15, 2019
July 15, 2019
NEW BRUNSWICK, New Jersey, July 15 -- Johnson and Johnson issued the following news release:
* * *
- National Institutes of Health (NIH), HIV Vaccine Trials Network And U.S. Army Medical Research And Development Command Join Forces With Johnson & Johnson to Advance Global Investigational Vaccine to Prevent HIV-1 Infection
* * *
Johnson & Johnson today announced that Janssen Vaccines & Prevention B.V., one of its Janssen Pharmaceutic . . .
* * *
- National Institutes of Health (NIH), HIV Vaccine Trials Network And U.S. Army Medical Research And Development Command Join Forces With Johnson & Johnson to Advance Global Investigational Vaccine to Prevent HIV-1 Infection
* * *
Johnson & Johnson today announced that Janssen Vaccines & Prevention B.V., one of its Janssen Pharmaceutic . . .